Last Few Days to Actively Participate in BELLUS Health Inc. Class Action and Lead Plaintiff Deadline: May 17, 2021 - Bronstein, Gewirtz & Grossman, LLC Biotech Investing
MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application Cannabis Investing News
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application Cannabis Investing News
New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression Medical Device Investing
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents Pharmaceutical Investing
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Soliton, Inc. Buyout Biotech Investing
Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis Biotech Investing
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors with Losses over $100K to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD Cannabis Investing News
